Itrarad 100 Capsule contains Itraconazole 100 mg, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane formation and leading to fungal cell death. This medication is indicated for the treatment of systemic and superficial mycoses, including blastomycosis, histoplasmosis, aspergillosis, onychomycosis, and other dermatophytic infections. Itrarad 100 Capsule is particularly effective against infections caused by Candida species and dermatophytes. The drug is administered orally and is well absorbed, with enhanced bioavailability when taken with food. It is metabolized primarily by the liver via the cytochrome P450 system and has a relatively long half-life, allowing for convenient dosing schedules. Caution is advised in patients with hepatic impairment, congestive heart failure, or those taking medications that may interact with itraconazole, such as certain statins, benzodiazepines, and calcium channel blockers. Common adverse effects include gastrointestinal disturbances, headache, and rash. Itrarad 100 Capsule should be used under medical supervision with appropriate monitoring to ensure efficacy and safety.

Dosage & How to Use